Lexology February 7, 2024
Benesch Friedlander Coplan & Aronoff LLP

The U.S. Department of Health and Human Services (“HHS”) and the Substance Abuse and Mental Health Service Administration (“SAMHSA”) published a final rule on Feb. 2, 2024, that cemented significant Pandemic-era flexibilities for individuals receiving treatment for Opioid Use Disorder (“OUD”) from Opioid Treatment Programs (“OTPs”). The rule aims to reduce barriers to care for OUD by permanently adopting telehealth and take-home treatment options that were initially permitted in response to the COVID-19 Pandemic. Additionally, the rule expands the types of practitioners covered under the rule, and subsequently enables them to provide more accessible OUD care to patients. The rule also made updates to OTP accreditation and certification standards to reflect a modern treatment environment and clarify various administrative issues.

...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Govt Agencies, HHS, Patient / Consumer, Provider
Another health care disruptor is set to join RFK Jr.’s team
Familiar face in the tech policy office
CDC sends disease experts to Texas as measles cases rise
HHS Secretary RFK Jr. Urges Parents to Consider Measles Shot
What HHS' public comment rollback means for hospitals: 3 federal health updates

Share This Article